Results for dextrometorfan hidrobromuro translation from Spanish to English

hidrobromuro
hydrobromide

dextrometorfano hidrobromuro
dextromethorphan hydrobromide

hidrobromuro de hidroxianfetamina
hydroxyamphetamine hydrobromide

alergia al hidrobromuro de dextrometorfano
dextromethorph hydrobr allergy

reacción adversa al hidrobromuro de dextrometorfano
dextromethorph hydrobr adv re

alergia al hidrobromuro de dextrometorfano (trastorno)
dextromethorph hydrobr allergy

hidrobromuro dextrometorfano, 6,67 mg/5 ml, jarabe
dextromethorphan hbr 20 mg/15 ml oral solution, oral

reacción adversa al hidrobromuro de dextrometorfano (trastorno)
dextromethorph hydrobr adv re

hidrobromuro dextrometorfano, 6,67 mg/5 ml, jarabe (producto)
dextromethorphan hbr 20 mg/15 ml oral solution, oral

cada cápsula contiene dextrometorfano hidrobromuro monohidratado, equivalente a 15,41 mg de dextrometorfano y quinidina sulfato dihidratada, equivalente a 8,69 mg de quinidina.
each capsule contains dextromethorphan hydrobromide monohydrate, equivalent to 15.41 mg dextromethorphan and quinidine sulfate dihydrate, equivalent to 8.69 mg quinidine.

cada cápsula de nuedexta 15 mg/9 mg contiene dextrometorfano hidrobromuro monohidratado, equivalente a 15,41 mg de dextrometorfano, y quinidina sulfato dihidratada, equivalente a 8,69 mg de quinidina.
each nuedexta 15 mg/9 mg capsule contains dextromethorphan hydrobromide monohydrate, equivalent to 15.41 mg dextromethorphan and quinidine sulfate dihydrate, equivalent to 8.69 mg quinidine.

en los estudios de toxicidad embriofetal y del desarrollo (ratas y conejos) con dextrometorfano hidrobromuro/quinidina sulfato, se observaron anomalías con dosis medias y altas con menor osificación desde la dosis menor en ratas que es de aproximadamente 1 y 50 veces la dosis para seres humanos de 30/18 mg/día en base a mg/m2, respectivamente.
in embryo-fetal and developmental toxicity studies (rats and rabbits) with dextromethorphan hydrobromide/quinidine sulfate, abnormalities were observed at mid and high dose with reduced ossification from the lowest dose in rats which is approximately 1 and 50 times the human dose of 30/18 mg/day on a mg/m2 basis, respectively.